These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16814680)

  • 1. Diagnosis and management of chronic heart failure.
    Aguiar-Souto P; Garcia-Pavia P; Silva-Melchor L; Ortigosa FJ
    J Am Coll Cardiol; 2006 Jul; 48(1):223; author reply 224. PubMed ID: 16814680
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
    Ferdinand KC
    J Law Med Ethics; 2008; 36(3):458-63. PubMed ID: 18840236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine and nitrates: beyond race and ethnicity.
    Ghali JK
    J Card Fail; 2007 Apr; 13(3):238. PubMed ID: 17448423
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term vasodilator therapy of chronic refractory heart failure in patients with dilated cardiomyopathy].
    Moriuchi M; Saito S; Tamura Y; Kaseda N; Tsuji M; Tokutake E; Yumikura S; Hibiya K; Ozawa Y; Hatano M
    J Cardiogr Suppl; 1986; (9):77-85. PubMed ID: 3093596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on outpatient treatment of systolic heart failure.
    Fiscella K
    Am Fam Physician; 2005 Oct; 72(7):1172, 1174. PubMed ID: 16225019
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined vasodilator therapy in the treatment of chronic heart failure.
    McGuinness JB; Ballantyne D; Baxter RH; Clark RS; Weir JI
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):43-4. PubMed ID: 7344601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
    Kirichenko LL; Gaĭdukova NI; Solov'eva FV
    Sov Med; 1986; (2):91-4. PubMed ID: 3704769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ambulatory treatment of chronic heart failure with peripheral vasodilators].
    Solonovich TG
    Kardiologiia; 1984 Nov; 24(11):113-4. PubMed ID: 6441064
    [No Abstract]   [Full Text] [Related]  

  • 11. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Flack JM
    Expert Opin Pharmacother; 2007 Feb; 8(3):275-7. PubMed ID: 17266462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
    Yancy CW; Feldman A
    Clin Transl Sci; 2009 Aug; 2(4):309-11. PubMed ID: 20443909
    [No Abstract]   [Full Text] [Related]  

  • 14. Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Franciosa JA
    Expert Opin Pharmacother; 2006 Dec; 7(18):2521-31. PubMed ID: 17150006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
    Sliwa K; Damasceno A; Davison BA; Mayosi BM; Sani MU; Ogah O; Mondo C; Ojji D; Dzudie A; Kouam CK; Yonga G; Ba SA; Ogola E; Edwards C; Milo O; Cotter G
    Eur J Heart Fail; 2016 Oct; 18(10):1248-1258. PubMed ID: 27206810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic range of transdermal nitro-patches].
    Lazebnik LB
    Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is the value of organic nitrate preparations in treatment of chronic heart failure?].
    Internist (Berl); 1996 Jul; 37(7):739. PubMed ID: 8830005
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
    Norgard NB; Stark JE
    Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasodilator effects of intravenous isosorbide dinitrate in patients with heart failure--multi-center studies].
    Hirosawa K; Kimata S; Kawai C; Kambara H; Hosoda S; Hayakawa H; Takano T; Yamaguchi H; Inoue M; Hiramori K
    Kokyu To Junkan; 1985 Jul; 33(7):903-12. PubMed ID: 3903903
    [No Abstract]   [Full Text] [Related]  

  • 20. BiDil flops.
    Huggett B
    Nat Biotechnol; 2008 Mar; 26(3):252. PubMed ID: 18327217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.